MedTrace Logo

Develop Novel Methods to Display, Report and Analyze CGM Data for Clinical Decision-Making in People With Diabetes

NCT00465881 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 30

Last updated 2015-12-03

No results posted yet for this study

Summary

The purpose of this study is to obtain sufficient continuous glucose monitoring (CGM) data in a manner that provides clinical information that is not available using conventional self-monitored blood glucose. Currently, a formal method does not exist for evaluating CGM data except for looking at each glucose reading across the days a CGM system has been worn and evaluating it based on clinical practice experience. The hope is that a mathematical model can be developed that will enable health care providers to quickly and easily determine what changes in diabetes treatment need to be made after CGM data is obtained.

Conditions

Interventions

DEVICE

CGM System for Type 1 and Type 2 Diabetes Mellitus

Sponsors & Collaborators

  • Abbott Diabetes Care

    collaborator INDUSTRY

  • HealthPartners Institute

    lead OTHER

Principal Investigators

  • Roger S. Mazze, PhD · International Diabetes Center - Park Nicollet Institute

  • Richard M. Bergenstal, MD · International Diabetes Center - Park Nicollet Institute

  • Ellie S. Strock, RN BC-ANP · International Diabetes Center - Park Nicollet Institute

Eligibility

Min Age
21 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-01-31
Completion
2006-04-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00465881 on ClinicalTrials.gov